[A prospective study of the efficacy and safety of maintenance therapy with recombinant human thrombopoietin in patients with primary immune thrombocytopenia: a multicenter study]
[一项关于重组人血小板生成素维持治疗原发性免疫性血小板减少症患者疗效和安全性的前瞻性研究:一项多中心研究]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2017.05.005
Cai, H C; Wang, S J; Fu, L; Wang, X M; Hou, M; Qin, P; Chen, F P; Zhang, X H; Huang, H; He, J S; Wu, R H; Ma, J Y; Yang, R C; Liu, X F; Tian, Y; Liu, A J; Wu, J S; Zhu, W W; Zhou, Y H; Liu, W B; Hu, Y; He, W J; Li, Y; Pan, D; Zhao, Y Q